GMA News
WHO hopes Philippines can tap up to 4k volunteers for Solidarity Trial
The World Health Organization (WHO) is urging the Philippines to increase its commitment to the global COVID-19 vaccine trial by pledging more volunteers.
WHO Country Representative Rabindra Abeyasinghe expressed hope that the Philippines would aim for up to 4,000 participants, exceeding the current target of 2,000 to 3,000.
He emphasized that a larger number of participants globally will accelerate the process of determining the safety and efficacy of potential vaccines.
Twelve hospitals across Metro Manila, Cavite, Cebu City, and Davao City have been identified as trial sites, chosen for their high COVID-19 transmission rates.
Participants will be between 18 and 60 years old, with exclusions for pregnant women and those with comorbidities to ensure vaccine safety is thoroughly evaluated.
The WHO is still finalizing which candidate vaccines will be included for the trial in the Philippines.
The Philippine government has allocated P89 million for the Solidarity Trial, a global effort to develop and evaluate possible COVID-19 vaccines.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The Department of Science and Technology (DOST) has started preparations for the COVID-19 vaccine trials in the country.
Read more →
Chinese pharmaceutical company Sinopharm has withdrawn its plan to conduct Phase 3 clinical trials for its COVID-19 vaccine in the Philippines.
Read more →
President Rodrigo R. Duterte announced that the Philippines has secured sufficient funds to purchase coronavirus vaccines once they become available.
Read more →
The Department of Trade and Industry (DTI) and the Russian embassy are exploring the possibility of establishing a COVID-19 vaccine plant in the Philippines.
Read more →
The Philippine Vaccine Expert Panel (VEP), chaired by the Department of Science and Technology, has cleared China's Sinovac COVID-19 vaccine for Phase 3 clinical trials in the country.
Read more →